Applying pharmacogenomics to enhance the use of biomarkers for drug effect and drug safety in patients with multiple myeloma: a step forward personalised medicine (Q3183561): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Added qualifier: readability score (P590521): 0.0469932973501916)
(‎Changed label, description and/or aliases in pt)
 
(One intermediate revision by the same user not shown)
label / ptlabel / pt
Aplicação de farmacogenômica para aumentar o uso de biomarcadores para efeito de drogas e segurança de medicamentos em pacientes com mieloma múltiplo: um passo em frente na medicina personalizada
Aplicação da farmacogenómica para aumentar a utilização de biomarcadores para o efeito do medicamento e a segurança do medicamento em doentes com mieloma múltiplo: um passo em frente na medicina personalizada
Property / summaryProperty / summary
Aplicação de farmacogenômica para aumentar o uso de biomarcadores para efeito de drogas e segurança de medicamentos em pacientes com mieloma múltiplo: um passo em frente na medicina personalizada (Portuguese)
Aplicação da farmacogenómica para aumentar a utilização de biomarcadores para o efeito do medicamento e a segurança do medicamento em doentes com mieloma múltiplo: um passo em frente na medicina personalizada (Portuguese)

Latest revision as of 09:56, 10 October 2024

Project Q3183561 in Spain
Language Label Description Also known as
English
Applying pharmacogenomics to enhance the use of biomarkers for drug effect and drug safety in patients with multiple myeloma: a step forward personalised medicine
Project Q3183561 in Spain

    Statements

    country
    Spain
    0 references
    EU contribution
    66,156.75 Euro
    0 references
    budget
    121,500.0 Euro
    0 references
    co-financing rate
    54.45 percent
    0 references
    start time
    1 January 2014
    0 references
    end time
    31 July 2017
    0 references
    beneficiary name (string)
    HOSPITAL UNIVERSITARIO DE SALAMANCA
    0 references
    coordinate location

    40°57'54.58"N, 5°39'50.47"W
    inferred from
    location
    0 references
    summary
    Applying pharmacogenomics to enhance the use of biomarkers for drug effect and drug safety in patients with multiple myeloma: a step forward personalized medicine (Spanish)
    0 references
    Applying pharmacogenomics to enhance the use of biomarkers for drug effect and drug safety in patients with multiple myeloma: a step forward personalised medicine (English)
    point in time
    12 October 2021
    readability score
    0.0469932973501916
    0 references
    Application de la pharmacogénomique pour améliorer l’utilisation de biomarqueurs pour l’effet médicamenteux et l’innocuité des médicaments chez les patients atteints de myélome multiple: un pas en avant en médecine personnalisée (French)
    point in time
    4 December 2021
    0 references
    Anwendung der Pharmakogenomics zur Verbesserung der Verwendung von Biomarkern für die Arzneimittelwirkung und die Arzneimittelsicherheit bei Patienten mit multiplem Myelom: ein Schritt nach vorn personalisierte Medizin (German)
    point in time
    9 December 2021
    0 references
    Het toepassen van farmacogenomica om het gebruik van biomarkers voor geneesmiddeleffect en geneesmiddelveiligheid te verbeteren bij patiënten met multipel myeloom: een stap voorwaarts gepersonaliseerde geneeskunde (Dutch)
    point in time
    17 December 2021
    0 references
    Applicazione della farmacogenomica per migliorare l'uso di biomarcatori per l'effetto farmacologico e la sicurezza del farmaco in pazienti con mieloma multiplo: un passo avanti nella medicina personalizzata (Italian)
    point in time
    16 January 2022
    0 references
    Farmakogenoomika rakendamine, et suurendada ravimi toime ja ravimi ohutuse biomarkerite kasutamist hulgimüeloomiga patsientidel: samm edasi personaliseeritud meditsiin (Estonian)
    point in time
    4 August 2022
    0 references
    Farmakogenomikos taikymas siekiant padidinti biologinių žymenų naudojimą vaistų poveikiui ir vaistų saugumui daugine mieloma sergantiems pacientams: žingsnis į priekį individualizuotos medicinos (Lithuanian)
    point in time
    4 August 2022
    0 references
    Primjena farmakogenomike za poboljšanje uporabe biomarkera za učinak lijeka i sigurnost lijekova u bolesnika s multiplim mijelomom: korak naprijed personalizirana medicina (Croatian)
    point in time
    4 August 2022
    0 references
    Εφαρμογή φαρμακογονιδιωματικής για την ενίσχυση της χρήσης βιοδεικτών για την επίδραση του φαρμάκου και την ασφάλεια των φαρμάκων σε ασθενείς με πολλαπλό μυέλωμα: ένα βήμα προς τα εμπρός εξατομικευμένη ιατρική (Greek)
    point in time
    4 August 2022
    0 references
    Použitie farmakogenomiky na zlepšenie používania biomarkerov pre účinok lieku a bezpečnosť liekov u pacientov s mnohopočetným myelómom: krok vpred personalizovaná medicína (Slovak)
    point in time
    4 August 2022
    0 references
    Farmakogenomiikan soveltaminen biomarkkerien käytön tehostamiseksi lääkevaikutuksiin ja lääketurvallisuuteen multippelia myeloomaa sairastavilla potilailla: askel eteenpäin henkilökohtainen lääketiede (Finnish)
    point in time
    4 August 2022
    0 references
    Stosowanie farmakogenomiki w celu zwiększenia stosowania biomarkerów do działania leku i bezpieczeństwa stosowania leku u pacjentów ze szpiczakiem mnogim: krok naprzód spersonalizowana medycyna (Polish)
    point in time
    4 August 2022
    0 references
    Farmakogenomika alkalmazása a mielóma multiplexben szenvedő betegeknél a gyógyszerhatást és a gyógyszerbiztonságot szolgáló biomarkerek használatának fokozására: lépés a személyre szabott orvoslás felé (Hungarian)
    point in time
    4 August 2022
    0 references
    Použití farmakogenomiky ke zlepšení používání biomarkerů pro účinek léčiv a bezpečnost léčiv u pacientů s mnohočetným myelomem: krok vpřed personalizovaná medicína (Czech)
    point in time
    4 August 2022
    0 references
    Farmakoloģiskie līdzekļi, lai uzlabotu biomarķieru lietošanu zāļu iedarbībai un zāļu drošumam pacientiem ar multiplo mielomu: solis uz personalizētu medicīnu (Latvian)
    point in time
    4 August 2022
    0 references
    Iarratas a dhéanamh ar pharmacogenomics chun feabhas a chur ar úsáid bithmharcóirí le haghaidh éifeacht drugaí agus sábháilteacht drugaí in othair a bhfuil myeloma iolrach: céim chun cinn leigheas pearsantaithe (Irish)
    point in time
    4 August 2022
    0 references
    Uporaba farmakogenomike za povečanje uporabe biomarkerjev za učinek zdravila in varnost zdravil pri bolnikih z diseminiranim plazmocitomom: korak naprej personalizirana medicina (Slovenian)
    point in time
    4 August 2022
    0 references
    Прилагане на фармакогеномика за подобряване на употребата на биомаркери за лекарствен ефект и лекарствена безопасност при пациенти с множествен миелом: стъпка напред персонализирана медицина (Bulgarian)
    point in time
    4 August 2022
    0 references
    Applikazzjoni ta’ farmakoġenomika biex ittejjeb l-użu ta’ bijomarkaturi għall-effett tal-mediċina u s-sigurtà tal-mediċina f’pazjenti b’majeloma multipla: pass’il quddiem tal-mediċina personalizzata (Maltese)
    point in time
    4 August 2022
    0 references
    Aplicação da farmacogenómica para aumentar a utilização de biomarcadores para o efeito do medicamento e a segurança do medicamento em doentes com mieloma múltiplo: um passo em frente na medicina personalizada (Portuguese)
    point in time
    4 August 2022
    0 references
    Anvendelse af farmakogenomik for at øge brugen af biomarkører for lægemiddeleffekt og lægemiddelsikkerhed hos patienter med multipelt myelomatose: et skridt fremad personlig medicin (Danish)
    point in time
    4 August 2022
    0 references
    Aplicarea farmacogenomicii pentru a spori utilizarea biomarkerilor pentru efectul medicamentos și siguranța medicamentelor la pacienții cu mielom multiplu: un pas înainte medicina personalizată (Romanian)
    point in time
    4 August 2022
    0 references
    Tillämpa farmakogenomik för att öka användningen av biomarkörer för läkemedelseffekt och läkemedelssäkerhet hos patienter med multipelt myelom: ett steg framåt individanpassad medicin (Swedish)
    point in time
    4 August 2022
    0 references
    location (string)
    Salamanca
    0 references
    date of last update
    20 December 2023
    0 references

    Identifiers

    Spanish Kohesio ID
    CP13_00080
    0 references
     
    Retrieved from "https://linkedopendata.eu/w/index.php?title=Item:Q3183561&oldid=43312005"